临床研究

糖尿病视网膜病变发展中的免疫图谱变化

  • 吴晓君 ,
  • 卜诗淼 ,
  • 陈湘婷 ,
  • 俞军 ,
  • 刘勇 ,
  • 张跃红 ,
  • 辛松青 ,
  • 刘雨丰
展开
  • 1.华南理工大学医学院附属第二医院 (广州 510006 )
    2.广州市第一人民医院眼科
    1.广州 510180 ),广东省东莞市常安医院检验科,(广东东莞 523000

收稿日期: 2023-07-12

  网络出版日期: 2023-11-22

基金资助

国家自然科学基金面上项目(8217060280);广东省自然科学基金面上项目(2114050002084);广州市基础与应用基础研究专题(优秀博士“续航”项目)(SL2024A04J00240);东莞市社会科技发展(重点)项目(20221800904962)

Immune mapping changes in the development of diabetic retinopathy

  • Xiaojun WU ,
  • Shimiao BU ,
  • Xiangting CHEN ,
  • Jun YU ,
  • Yong LIU ,
  • Yuehong ZHANG ,
  • Songqing XIN ,
  • Yufeng. LIU
Expand
  • *.The Second Affiliated Hospital,School of Medicine,South China University of Technology,Guangzhou 510006,China

Received date: 2023-07-12

  Online published: 2023-11-22

摘要

目的 为解析糖尿病向糖尿病视网膜病变进展的免疫学调控机制,流式细胞术分析健康人(health donor,HD)、糖尿病患者(diabetes mellitus,DM)、非增殖型糖尿病视网膜病变患者(non-proliferative diabetic retinopathy, NPDR)以及增殖型糖尿病视网膜病变患者(proliferative diabetic retinopathy, PDR)外周血中的免疫细胞图谱之间的差异。 方法 收集HD、DM、NPDR以及PDR患者的外周血,采用密度梯度离心法分离获得外周血免疫细胞。13色流式抗体共同染色并上流式细胞仪进行检测。结合Flowjo及其插件对细胞进行降维及聚类处理分析,最后采用Spearman相关性分析及受试者工作特征(receiver operating characteristic,ROC)曲线评估外周血免疫细胞预测DM到DR阶段进展的诊断价值。 结果 将外周血免疫细胞分为10大群,在固有免疫细胞中,DM和PDR中mono-classical细胞群较健康人升高(P < 0.05);适应性免疫细胞中,DM和NPDR中的B细胞较HD组升高(P < 0.05),NKT、T细胞则较HD组下降(P < 0.05);PDR中的B细胞和健康人对比则均升高(P < 0.05),但T细胞下降(P < 0.05)。此外,B细胞和各阶段呈正相关,并且在PDR阶段中,ROC曲线分析B细胞预测DM到DR阶段进展的效能大于其他免疫细胞。 结论 健康人、DM和DR患者的3个阶段的外周血免疫细胞图谱之间存在差异,此外B细胞和各阶段正相关,有着预测疾病进展的诊断价值的潜力。

本文引用格式

吴晓君 , 卜诗淼 , 陈湘婷 , 俞军 , 刘勇 , 张跃红 , 辛松青 , 刘雨丰 . 糖尿病视网膜病变发展中的免疫图谱变化[J]. 实用医学杂志, 2023 , 39(19) : 2517 -2523 . DOI: 10.3969/j.issn.1006-5725.2023.19.018

Abstract

Objective To analyze the immunological regulation mechanism of the progression of diabetes to diabetic retinopathy. We used Flow cytometry to compare the differences of immune cell profiles in peripheral blood of healthy donors (HD), diabetic patients (DM), non-proliferative diabetic retinopathy patients (NPDR) and proliferative diabetic retinopathy patients (PDR). Methods Peripheral blood was collected from HD, DM, NPDR and PDR, and peripheral blood immune cells were isolated by density gradient centrifugation. The 13-color flow cytometry antibody was co-stained and detected by flow cytometry. Combined with Flowjo and its plug-in, the cells were analyzed by dimensionality reduction and clustering. Finally, Spearman correlation analysis and receiver operating characteristic (ROC) curve were used to evaluate the diagnostic value of peripheral blood immune cells in predicting the progression from DM to DR stage. Results Peripheral blood immune cells were divided into 10 groups. Among the innate immune cells, the number of mono-classical cells in DM and PDR was higher than that in healthy people (P < 0.05). In adaptive immune cells, B cells in DM and NPDR were higher than those in HD group (P < 0.05), while NKT and T cells were lower than those in HD group (P < 0.05). Compared with healthy people, B cells in PDR were increased (P < 0.05), but T cells were decreased (P < 0.05). In addition, B cells were positively correlated with each stage. And in the PDR stage, ROC curve analysis showed that the efficiency of B cells in predicting the progression of DM to DR was greater than that of other immune cells. Conclusion Differences were noted between the three stages of peripheral blood immune cell profiles in HD, DM and DR. In addition, B cells were positively correlated with each stage, and had the potential to predict the diagnostic value of disease progression.

参考文献

1 OGURTSOVA K, ROCHA FERNANDES J D DA, HUANG Y, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040 [J]. Diabetes Res Clin Pract, 2017, 128: 40-50.
2 杨燕卓, 申红霞,韩瑞敏,等. 新型降糖药物治疗2型糖尿病的研究进展 [J]. 实用医学杂志, 2023, 39(2): 153-157.
3 ROBINSON R, BARATHI V A, CHAURASIA S S, et al. Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals [J]. Dis Model Mech, 2012, 5(4): 444-456.
4 IBRAHIM A S, EL-REMESSY A B, MATRAGOON S, et al. Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes [J]. Diabetes, 2011, 60(4): 1122-1133.
5 COUGHLIN B A, FEENSTRA D J, MOHR S. Müller cells and diabetic retinopathy [J]. Vision Res, 2017, 139: 93-100.
6 STEINLE J J. Role of HMGB1 signaling in the inflammatory process in diabetic retinopathy [J]. Cell Signal, 2020, 73: 109687.
7 中华医学会眼科学分会眼底病学组.我国糖尿病视网膜病变临床诊疗指南(2014年) [J]. 中华眼科杂志, 2014, 50(11): 851-865.
8 GORDON S, TAYLOR P R. Monocyte and macrophage heterogeneity [J]. Nat Rev Immunol, 2005, 5(12): 953-964.
9 FADINI G P, DE KREUTZENBERG S V, BOSCARO E, et al. An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy [J]. Diabetologia, 2013, 56(8): 1856-1866.
10 WAN H, CAI Y, WANG Y, et al. The unique association between the level of peripheral blood monocytes and the prevalence of diabetic retinopathy: a cross-sectional study [J]. J Transl Med, 2020, 18(1): 248.
11 ZENG C, SHI X, ZHANG B, et al. The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications [J]. J Mol Med (Berl), 2012, 90(2): 175-186.
12 ABDEL-MONEIM A, BAKERY H H, ALLAM G. The potential pathogenic role of IL-17/Th17 cells in both type 1 and type 2 diabetes mellitus [J]. Biomed Pharmacother, 2018, 101: 287-292.
13 LIU S, LIN Y U, LIU X. Protective effects of SIRT1 in patients with proliferative diabetic retinopathy via the inhibition of IL-17 expression [J]. Exp Ther Med, 2016, 11(1): 257-262.
14 DELIYANTI D, FIGGETT W A, GEBHARDT T, et al. CD8(+) T Cells Promote Pathological Angiogenesis in Ocular Neovascular Disease [J]. Arterioscler Thromb Vasc Biol, 2023, 43(4): 522-536.
15 MENART-HOUTERMANS B, TTER R R, NOWOTNY B, et al. Leukocyte profiles differ between type 1 and type 2 diabetes and are associated with metabolic phenotypes: results from the German Diabetes Study (GDS) [J]. Diabetes Care, 2014, 37(8): 2326-2333.
16 LV X, GAO Y, DONG T, et al. Role of Natural Killer T (NKT) Cells in Type II Diabetes-Induced Vascular Injuries [J]. Med Sci Monit, 2018, 24: 8322-8332.
17 GUO H, XU B, GAO L, et al. High frequency of activated natural killer and natural killer T-cells in patients with new onset of type 2 diabetes mellitus [J]. Exp Biol Med (Maywood), 2012, 237(5): 556-562.
18 DENG C, XIANG Y, TAN T, et al. Altered Peripheral B-Lymphocyte Subsets in Type 1 Diabetes and Latent Autoimmune Diabetes in Adults [J]. Diabetes Care, 2016, 39(3): 434-40.
19 YU H, LIU B, WU G, et al. Dysregulation of circulating follicular helper T cells in type 2 diabetic patients with diabetic retinopathy [J]. Immunol Res, 2021, 69(2): 153-161.
20 LIU B, HU Y, WU Q, et al. Qualitative and Quantitative Analysis of B-Cell-Produced Antibodies in Vitreous Humor of Type 2 Diabetic Patients with Diabetic Retinopathy [J]. J Diabetes Res, 2020, 2020: 4631290.
21 WANG C, YOU Q, CAO X, et al. Micro RNA-19a suppresses interleukin-10 in peripheral B cells of patients with diabetic retinopathy [J]. Am J Transl Res, 2017, 9(3): 1410-1417.
文章导航

/